Community-acquired pneumonia by Legionella pneumophila. Do we need to include new recommendations for inflammatory bowel disease patients under immunomodulators?

Fernández-Llamas, Tania; Sánchez-Torres, Antonio; Egea-Valenzuela, Juan

RICSMUR Principal
→
02. Servicio Murciano de Salud (SMS)
→
02.01. Área de Salud I Murcia Oeste
→
02.01.01. Investigación y comunicación científica
→
Ver ítem

dc.contributor.author	Fernández-Llamas, Tania
dc.contributor.author	Sánchez-Torres, Antonio
dc.contributor.author	Egea-Valenzuela, Juan
dc.date.accessioned	2026-10-21T06:19:45Z
dc.date.available	2026-10-21T06:19:45Z
dc.date.issued	2016
dc.identifier.citation	Fernández Llamas T, Sánchez Torres A, Egea Valenzuela J. Community-acquired pneumonia by Legionella pneumophila. Do we need to include new recommendations for inflammatory bowel disease patients under immunomodulators? Rev Esp Enferm Dig. 2016;108. doi:10.17235/reed.2016.4213/2016
dc.identifier.issn	1130-0108
dc.identifier.uri	https://sms.carm.es/ricsmur/handle/123456789/28865
dc.description.abstract	We present the case of a community-acquired pneumonia by Legionella Pneumophila in a 31-year-old patient with Crohn's disease under anti-TNF agents. Following this and other similar cases reported in literature, we propose to include recommendations to prevent this infection in patients starting treatment with immunosuppressant drugs through simple measures regarding the control of water in the patients' home.
dc.language.iso	spa
dc.rights	Atribución/Reconocimiento-NoComercial-SinDerivados 4.0 Internaciona
dc.rights.uri	https://creativecommons.org/licenses/by-nc-nd/4.0/deed.es	*
dc.subject.mesh	Adrenal Cortex Hormones/adverse effects/therapeutic use
dc.subject.mesh	Adult
dc.subject.mesh	Community-Acquired Infections/complications/drug therapy
dc.subject.mesh	Female
dc.subject.mesh	Humans
dc.subject.mesh	Immunologic Factors/adverse effects/therapeutic use
dc.subject.mesh	Inflammatory Bowel Diseases/complications/drug therapy
dc.subject.mesh	Infliximab/adverse effects/therapeutic use
dc.subject.mesh	Legionnaires' Disease/complications/drug therapy
dc.title	Community-acquired pneumonia by Legionella pneumophila. Do we need to include new recommendations for inflammatory bowel disease patients under immunomodulators?
dc.type	info:eu-repo/semantics/article
dc.identifier.pmid	26937888
dc.relation.publisherversion	https://online.reed.es/fichaArticulo.aspx?iarf=683764744235-413275192167
dc.identifier.doi	10.17235/reed.2016.4213/2016
dc.journal.title	Revista Española de Enfermedades Digestivas
dc.identifier.essn	2340-4167